+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Racial differences in the incidence of breast cancer subtypes defined by combined histologie grade and hormone receptor status



Racial differences in the incidence of breast cancer subtypes defined by combined histologie grade and hormone receptor status



Cancer Causes & Control 21(3): 399-409




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063975767

Download citation: RISBibTeXText

DOI: 10.2307/40645723


Related references

Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status. Cancer Causes and Control 21(3): 399-409, 2010

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. Journal of the National Cancer Institute 106(5), 2014

The impact of sociodemographic factors, hormone receptor status, and tumor grade on racial/ethnic differences in tumor stage and size for breast cancer in US women. American Journal of Epidemiology 153(11 Suppl.): S202, June 1, 2001

The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status. Plos One 10(12): E0144680, 2016

Dietary cadmium and risk of breast cancer subtypes defined by hormone receptor status: a prospective cohort study. International Journal of Cancer 2018, 2018

Impact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy Reconstruction. Medicine 95(3): E2547, 2016

Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women. Plos One 12(2): E0171198, 2017

Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Research and Treatment 120(1): 149-160, 2010

Racial/Ethnic Differences in the Use and Discontinuation of Adjuvant Endocrine Therapy by Hormone-Receptor Status in Association with Mortality among Breast Cancer Patients Enrolled in Medicare Part D. Cancer Epidemiology Biomarkers & Prevention 26(3): 437.3-438, 2017

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. British Journal of Cancer 93(3): 364-371, 2005

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Journal of the National Cancer Institute 99(15): 1152-1161, 2007

Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data. Cancer Epidemiology, Biomarkers and Prevention 23(11): 2311-2321, 2015

Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. American Journal of Epidemiology 155(6): 534-545, 2002

Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database. Journal of Cancer Research and Clinical Oncology 143(1): 161-168, 2016

Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study. Breast Cancer Research and Treatment 140(3): 557-565, 2014